As drugs are evolving, altered variants of fentanyl and other opioids are forcing first responders to tackle drug overdoses ...

A company insider will step into its top job with a goal of reviving Target's reputation as the place to go for affordable but stylish products.

On July 31, the Trump administration called on drug manufacturers to lower prescription drug prices in the U.S. to "most favored nation" – or MFN – pricing, the lowest cost paid for the same ...

Rob Abbott, CEO, ISPOR, highlights how uniting regulators, payers, and academic leaders worldwide can accelerate access to innovative treatments and strengthen evidence-based healthcare.

Urban Meyer circles back to unfair punishment given to Ohio State after Michigan sign-stealing verdict Education Department ...

On May 12, Trump signed an executive order stating that U.S. consumers are being overcharged for prescription drugs and that ...

Votoplam (PTC518) for Huntington's Disease shows promising phase 2 results; a key FDA meeting in Q4 2025 could enable ...

CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to its commercial plans for now, a spokesperson told Reuters, despite the ...

GoodRx and Novo Nordisk are partnering to lower costs for Ozempic and Wegovy. Patients can use GoodRx to access ...

The state must cut $100 million from State Health Benefits Program, which has faced double-digit premium hikes for the last ...

Regulations aiming to lower the cost of vital medicines will instead end up restricting access and disincentivizing R&D.

Today’s Forbes Daily covers the fallout over Elon Musk's self-driving claims, a dose of reality on Wall Street, weight loss drug player takes a hit and more.